Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Stéphane T. Temmerman"'
Autor:
Saaussan Madi, Fang Xie, Kamyar Farhangi, Chih-Yang Hsu, Shih-Hsun Cheng, Tolulope Aweda, Bhasker Radaram, Stephanie Slania, Tammy Lambert, Mary Rambo, Tina Skedzielewski, Austin Cole, Valeriia Sherina, Shannon McKearnan, Hoang Tran, Hasan Alsaid, Minh Doan, Alan H. Stokes, Derek T. O’Hagan, Giulietta Maruggi, Sylvie Bertholet, Stéphane T. Temmerman, Russell Johnson, Beat M. Jucker
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
The goal of this study was to utilize a multimodal magnetic resonance imaging (MRI) and positron emission tomography (PET) imaging approach to assess the local innate immune response in skeletal muscle and draining lymph node following vaccination in
Externí odkaz:
https://doaj.org/article/f8cb07fbb3844bfdbcb71445fb51ca9e
Autor:
Catherine Collignon, Vanesa Bol, Aurélie Chalon, Naveen Surendran, Sandra Morel, Robert A. van den Berg, Stefania Capone, Viviane Bechtold, Stéphane T. Temmerman
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Replication-deficient chimpanzee adenovirus (ChAd) vectors represent an attractive vaccine platform and are thus employed as vaccine candidates against several infectious diseases. Since inducing effective immunity depends on the interplay between in
Externí odkaz:
https://doaj.org/article/9a4163532f2c4744ab74ffa266162604
Autor:
Paul R. Buckley, Kieran Alden, Margherita Coccia, Aurélie Chalon, Catherine Collignon, Stéphane T. Temmerman, Arnaud M. Didierlaurent, Robbert van der Most, Jon Timmis, Claus A. Andersen, Mark C. Coles
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Novel adjuvant technologies have a key role in the development of next-generation vaccines, due to their capacity to modulate the duration, strength and quality of the immune response. The AS01 adjuvant is used in the malaria vaccine RTS,S/AS01 and i
Externí odkaz:
https://doaj.org/article/5a240aa006c54bf8a92b460c8d920e74
Autor:
Jon Timmis, Robbert van der Most, Aurélie Chalon, Catherine Collignon, Kieran Alden, Claus A. Andersen, Mark Coles, Paul Buckley, Margherita Coccia, Arnaud M. Didierlaurent, Stéphane T. Temmerman
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol. 10 (2019) P. 2150
Frontiers in Immunology, Vol 10 (2019)
Frontiers in Immunology, Vol. 10 (2019) P. 2150
Frontiers in Immunology, Vol 10 (2019)
Novel adjuvant technologies have a key role in the development of next-generation vaccines, due to their capacity to modulate the duration, strength and quality of the immune response. The AS01 adjuvant is used in the malaria vaccine RTS,S/AS01 and i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8418a359093ad1a455e1aa8e00624da
http://europepmc.org/articles/PMC6751289
http://europepmc.org/articles/PMC6751289
Autor:
François Roman, Wivine Burny, Maria Angeles Ceregido, Béatrice Laupèze, Stéphane T Temmerman, Lucile Warter, Margherita Coccia
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 715-729 (2024)
Introduction The use of novel adjuvants in human vaccines continues to expand as their contribution to preventing disease in challenging populations and caused by complex pathogens is increasingly understood. AS01 is a family of liposome-based vaccin
Externí odkaz:
https://doaj.org/article/81dc6633736e41b888d3b814f3660234